Every story in this section, newest first — page 256 of 373.
bioAffinity Technologies (NASDAQ:BIAF) reported fiscal year 2025 results that underscore an aggressive transition from a broad laboratory service model to a specialized, high-growth diagnostic powerhouse focused on early-stage lung cancer detection.
Savara (NASDAQ:SVRA) provided a year-end financial update that underscores the company’s transition toward the commercial stage, with increased spending on pre-launch activities for its lead drug candidate, molgramostim.
Kestrel Group (NASDAQ:KG) delivered a bifurcated set of results for its fiscal year ended December 31, 2025, characterized by a massive surge in its fee-based business and a heavy fourth-quarter net loss due to specific one-time accounting charges.
Acurx Pharmaceuticals (NASDAQ:ACXP) on Friday reported a full-year 2025 net loss of $8 million, with cash and cash equivalents of $7.6 million as of December 31, 2025, supported by approximately $4 million in gross proceeds from its equity line of credit during the year.
AC Immune (NASDAQ:ACIU) unveiled clinical data on Friday suggesting its experimental vaccine could potentially slow the progression of Parkinson’s disease, a milestone that accompanied a significant corporate restructuring aimed at preserving its capital.
The ONE Group Hospitality (NASDAQ:STKS) reported a complex fourth quarter for fiscal 2025, marked by a strategic contraction of its portfolio and a calendar shift that dampened its traditional holiday revenue peak.
Better Home & Finance Holding Company (NASDAQ:BETR) delivered a sharp increase in operational momentum for the fourth quarter of 2025, signaling that its AI-native mortgage platform is beginning to capture significant market share as the interest rate environment shifts.
Douglas Elliman (NYSE:DOUG) turned a corner in fiscal 2025, moving from a steep loss to a net profit.
Waldencast (NASDAQ:WALD) reported a transformative finish to fiscal year 2025, prioritizing balance sheet stability through a series of strategic divestitures and debt restructurings while navigating mixed performance across its core brand portfolio.
The Buckle (NYSE:BKE) delivered a solid conclusion to its 2025 fiscal year, posting gains in both top-line revenue and net income as the denim-focused retailer continues to navigate a shifting consumer landscape.
Voyager Acquisition (NASDAQ:VACH) moved one step closer to finalizing its merger with Veraxa Biotech following an extraordinary general meeting on March 12, 2026.
Emerald Holding (NYSE:EEX) reported a significant expansion of its top-line results for fiscal year 2025, fueled by the aggressive integration of new event brands and a steady recovery in organic attendance across its core trade show portfolio.
Century Casinos (NASDAQ:CNTY) reported a stark contrast between its operational efficiency and its bottom-line results for the fiscal year ended Dec. 31, 2025.
Adobe (NASDAQ:ADBE) shares plummeted on Friday, wiping out billions in market value after the creative software giant announced that Shantanu Narayen will step down as Chief Executive Officer.
Innovative Industrial Properties (NYSE:IIPR) signaled continued confidence in its cash flow profile on Friday, declaring a first-quarter 2026 dividend that keeps its annualized payout among the highest in the specialized real estate sector.
RLX Technology (NYSE:RLX) delivered a robust financial performance for fiscal year 2025, demonstrating a successful pivot toward international markets as the e-vapor leader navigates a shifting regulatory landscape in its home market of China.
Eupraxia Pharmaceuticals (NASDAQ:EPRX) has secured a long-term financial runway, shifting focus toward pivotal data readouts for its lead gastrointestinal program following a successful fourth quarter and a transformative February financing.
Pony.ai (NYSE:PONY) took a significant step toward the mass-market commercialization of autonomous driving on March 13, 2026, by integrating its driverless robotaxi service directly into the Tencent Mobility Service via WeChat.
Greenfire Resources (NYSE:GFR) achieved a major financial de-leveraging milestone in 2025, moving to a debt-free position while delivering production results that surpassed its annual targets.
Kyivstar Group (NASDAQ:KYIV), the first Ukrainian company to list on the Nasdaq, delivered a robust performance for fiscal year 2025, signaling that its evolution into a diversified digital operator is successfully offsetting the challenges of a volatile operating environment.
VEON (NASDAQ:VEON) reported a record-breaking finish to 2025, with fourth-quarter results significantly exceeding market expectations on the back of rapid expansion into digital financial services and entertainment.
HIVE Digital Technologies (NASDAQ:HIVE) and AMC Robotics (NASDAQ:AMCI) have entered a strategic partnership to bridge the gap between heavy-duty robotics and high-performance cloud computing.
Precision BioSciences (NASDAQ:DTIL) reported a sharp swing to profitability in its final quarter of 2025, a result primarily driven by the recognition of deferred revenue from its heavyweight partnerships in the genome-editing space.
G-III Apparel Group (NASDAQ:GIII) on Wednesday reported fiscal 2026 net sales of $2.96 billion for the period ended January 31, 2026, a decrease of 7% from the prior year, reflecting softer wholesale demand in certain categories and ongoing challenges in the retail apparel environment.
